PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are: To evaluate pharmacokinetics (PK) properties of
BIIB074 administered as a single oral dose in healthy Japanese and Caucasian participants;
and To evaluate the PK properties of BIIB074 administered as repeated oral doses in healthy
Japanese participants. The secondary objective of this study is to assess the safety and
tolerability of BIIB074 administered as a single oral dose (Japanese and Caucasian
participants) and as repeated oral doses (Japanese participants).